InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Meyer Colin John, Directeur de la Recherche. Director active across 1 companies, notably Reata Pharmaceuticals INC. Aggregated, 4 reports have been logged. The latest transaction was filed on 3 January 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations4 total
035,000 shares0
Class A common stock
SEC:0001209191-22-001635·
035,000 shares0
Class A common stock
SEC:0001209191-22-001635:0·
5,000 shares
Class A common stock
SEC:0001209191-21-040884·
5,000 shares
Class A common stock
SEC:0001209191-21-040884:0·
4 of 4 declarations
About Meyer Colin John
Colin John Meyer serves as Chief Research Officer at REATA PHARMACEUTICALS INC. He is responsible for leading the company's research and development efforts, contributing to innovation and advancement in pharmaceutical projects. His scientific expertise is essential for the company's success.
